Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Ironwood Pharmaceuticals (IRWD) over the last 7 years, with Q3 2025 value amounting to 0.95%.

  • Ironwood Pharmaceuticals' Return on Invested Capital fell 4800.0% to 0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.95%, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of 0.26% for FY2024, which is 37500.0% up from last year.
  • Ironwood Pharmaceuticals' Return on Invested Capital amounted to 0.95% in Q3 2025, which was down 4800.0% from 0.22% recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Return on Invested Capital ranged from a high of 7.59% in Q1 2024 and a low of 3.45% during Q2 2023
  • Its 5-year average for Return on Invested Capital is 1.24%, with a median of 0.31% in 2022.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Return on Invested Capital skyrocketed by 99300bps in 2021 and then tumbled by -76900bps in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.86% in 2021, then tumbled by -68bps to 0.28% in 2022, then soared by 2556bps to 7.42% in 2023, then plummeted by -103bps to 0.19% in 2024, then plummeted by -407bps to 0.95% in 2025.
  • Its Return on Invested Capital was 0.95% in Q3 2025, compared to 0.22% in Q2 2025 and 0.09% in Q1 2025.